Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort

被引:0
|
作者
Rasha N. M. Saleh
Michael Hornberger
Craig W. Ritchie
Anne Marie Minihane
机构
[1] University of East Anglia,Norwich Medical School
[2] University of Edinburgh,Centre for Clinical Brain Sciences
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 8 条
  • [1] Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort
    Saleh, Rasha N. M.
    Hornberger, Michael
    Ritchie, Craig W.
    Minihane, Anne Marie
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [2] Cognitive Dispersion Is Not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Results from the European Prevention of Alzheimer's Dementia (EPAD) v500.0 Cohort
    Watermeyer, Tam
    Marroig, Alejandra
    Ritchie, Craig W.
    Ritchie, Karen
    Blennow, Kaj
    Muniz-Terrera, Graciela
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (01) : 185 - 194
  • [3] Associations of endogenous estrogens, plasma Alzheimer's disease biomarkers, and APOE4 carrier status on regional brain volumes in postmenopausal women
    Wugalter, Katrina A.
    Schroeder, Rachel A.
    Thurston, Rebecca C.
    Wu, Minjie
    Aizenstein, Howard J.
    Cohen, Ann D.
    Kamboh, M. Ilyas
    Karikari, Thomas K.
    Derby, Carol A.
    Maki, Pauline M.
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [4] Menopausal hormone therapy is associated with worse levels of Alzheimer's disease biomarkers in APOE ε4-carrying women: An observational study
    Jauregi-Zinkunegi, Ainara
    Gleason, Carey E.
    Bendlin, Barbara
    Okonkwo, Ozioma
    Hermann, Bruce P.
    Blennow, Kaj
    Zetterberg, Henrik
    Hogervorst, Eef
    Johnson, Sterling C.
    Langhough, Rebecca
    Mueller, Kimberly D.
    Bruno, Davide
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [5] Hormonal Replacement Therapy and Risk of Ulcerative Colitis and Crohn's Disease Among Postmenopausal Women: Results From a Large Prospective Cohort of US Women
    Khalili, Hamed
    Higuchi, Leslie M.
    Ananthakrishnan, Ashwin N.
    Richter, James M.
    Fuchs, Charles S.
    Chan, Andrew T.
    GASTROENTEROLOGY, 2012, 142 (05) : S88 - S89
  • [6] MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOE ε4 Noncarriers: Results from the Dementia Genetics Spanish Consortium
    Pastor, Pau
    Moreno, Fermin
    Clarimon, Jordi
    Ruiz, Agustin
    Combarros, Onofre
    Calero, Miguel
    Lopez de Munain, Adolfo
    Bullido, Maria J.
    de Pancorbo, Marian M.
    Carro, Eva
    Antonell, Anna
    Coto, Eliecer
    Ortega-Cubero, Sara
    Hernandez, Isabel
    Tarraga, Lluis
    Boada, Merce
    Lleo, Alberto
    Dols-Icardo, Oriol
    Kulisevsky, Jaime
    Luis Vazquez-Higuera, Jose
    Infante, Jon
    Rabano, Alberto
    Angel Fernandez-Blazquez, Miguel
    Valenti, Meritxell
    Indakoetxea, Begona
    Barandiaran, Myriam
    Gorostidi, Ana
    Frank-Garcia, Ana
    Sastre, Isabel
    Lorenzo, Elena
    Pastor, Maria A.
    Elcoroaristizabal, Xabier
    Lennarz, Martina
    Maier, Wolfang
    Ramirez, Alfredo
    Serrano-Rios, Manuel
    Lee, Suzee E.
    Sanchez-Juan, Pascual
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 49 (02) : 343 - 352
  • [7] Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease
    Hey, John A.
    Abushakra, Susan
    Blennow, Kaj
    Reiman, Eric M.
    Hort, Jakub
    Prins, Niels D.
    Sheardova, Katerina
    Kesslak, Patrick
    Shen, Larry
    Zhu, Xinyi
    Albayrak, Adem
    Paul, Jijo
    Schaefer, Jean F.
    Power, Aidan
    Tolar, Martin
    DRUGS, 2024, 84 (07) : 811 - 823